Ginkgo Bioworks Holdings, Inc. (DNA) Stock Slides as Market Rises: Facts to Know Before You Trade [Yahoo! Finance]
Ginkgo Bioworks Holdings, Inc. (DNA)
Company Research
Source: Yahoo! Finance
This move lagged the S&P 500's daily gain of 0.4%. Elsewhere, the Dow gained 0.62%, while the tech-heavy Nasdaq added 0.6%. The company's stock has climbed by 9.6% in the past month, exceeding the Medical sector's loss of 2.27% and the S&P 500's gain of 1.71%. The investment community will be closely monitoring the performance of Ginkgo Bioworks Holdings, Inc. in its forthcoming earnings report. The company's upcoming EPS is projected at -$2.80, signifying a 22.22% increase compared to the same quarter of the previous year. Meanwhile, our latest consensus estimate is calling for revenue of $43.92 million, down 20.77% from the prior-year quarter. For the entire fiscal year, the Zacks Consensus Estimates are projecting earnings of -$12.60 per share and a revenue of $182.13 million, representing changes of +19.23% and -27.57%, respectively, from the prior year. Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Ginkgo Bioworks Holdings, In
Show less
Read more
Impact Snapshot
Event Time:
DNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DNA alerts
High impacting Ginkgo Bioworks Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
DNA
News
- NOVUS Leverages Ginkgo Bioworks to Develop Innovative Feed Additives for Animal AgriculturePR Newswire
- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) had its price target raised by analysts at TD Cowen from $3.00 to $10.00. They now have a "buy" rating on the stock.MarketBeat
- Pomerantz LLP Announces that this is a Reminder of a Proposed Class Action Settlement on Behalf of Purchasers of Ginkgo Bioworks Holdings, Inc. Common Stock - DNAGlobeNewswire
- Ginkgo Bioworks Launches Ginkgo Datapoints to Transform AI Model Training in Biology [Yahoo! Finance]Yahoo! Finance
- Ginkgo Bioworks Launches Ginkgo Datapoints to Transform AI Model Training in BiologyPR Newswire
DNA
Earnings
- 8/8/24 - Miss
DNA
Sec Filings
- 9/27/24 - Form 144
- 9/26/24 - Form 144
- 9/25/24 - Form 144
- DNA's page on the SEC website